These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27546841)

  • 1. Pancreatic Cancer: A Review.
    Yabar CS; Winter JM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):429-45. PubMed ID: 27546841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of pancreatic neoplasms.
    Balachandran A; Bhosale PR; Charnsangavej C; Tamm EP
    Surg Oncol Clin N Am; 2014 Oct; 23(4):751-88. PubMed ID: 25246049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.
    Fogel EL; Shahda S; Sandrasegaran K; DeWitt J; Easler JJ; Agarwal DM; Eagleson M; Zyromski NJ; House MG; Ellsworth S; El Hajj I; O'Neil BH; Nakeeb A; Sherman S
    Am J Gastroenterol; 2017 Apr; 112(4):537-554. PubMed ID: 28139655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brca2 deficiency and Trp53 deregulation in pancreatic cancer: implications for therapeutic targeting.
    Yee NS
    Cancer Biol Ther; 2011 Jun; 11(11):969-73. PubMed ID: 21610317
    [No Abstract]   [Full Text] [Related]  

  • 5. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.
    Couch FJ; Johnson MR; Rabe K; Boardman L; McWilliams R; de Andrade M; Petersen G
    Cancer Res; 2005 Jan; 65(2):383-6. PubMed ID: 15695377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and Biology of Pancreatic Ductal Adenocarcinoma.
    Dunne RF; Hezel AF
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):595-608. PubMed ID: 26226899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
    Witkiewicz AK; McMillan EA; Balaji U; Baek G; Lin WC; Mansour J; Mollaee M; Wagner KU; Koduru P; Yopp A; Choti MA; Yeo CJ; McCue P; White MA; Knudsen ES
    Nat Commun; 2015 Apr; 6():6744. PubMed ID: 25855536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anemia gene mutations in young-onset pancreatic cancer.
    van der Heijden MS; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 2003 May; 63(10):2585-8. PubMed ID: 12750283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Chronic Pancreatitis to Pancreatic Cancer: Is There a Role of Gene Mutations as a Screening Tool?
    Rashid S; Singh N; Gupta S; Rashid S; Nalika N; Sachdev V; Bal CS; Datta Gupta S; Chauhan SS; Saraya A
    Pancreas; 2018 Feb; 47(2):227-232. PubMed ID: 29303908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: An update on diagnosis and management.
    Loveday BPT; Lipton L; Thomson BN
    Aust J Gen Pract; 2019 Dec; 48(12):826-831. PubMed ID: 31774983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.
    Semaan A; Maitra A
    Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):76-78. PubMed ID: 29317774
    [No Abstract]   [Full Text] [Related]  

  • 13. Mouse Models of Pancreatic Ductal Adenocarcinoma.
    Ponz-Sarvise M; Tuveson DA; Yu KH
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):609-17. PubMed ID: 26226900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of pancreatic cancer.
    De La Cruz MS; Young AP; Ruffin MT
    Am Fam Physician; 2014 Apr; 89(8):626-32. PubMed ID: 24784121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifiable and non-modifiable risk factors for pancreatic cancer: A review.
    Midha S; Chawla S; Garg PK
    Cancer Lett; 2016 Oct; 381(1):269-77. PubMed ID: 27461582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An Evaluation of Outcome of Surgical Treatment for Recurrence after Curative Pancreatectomy for Pancreatic Ductal Cancer].
    Miyamoto A; Maeda S; Hama N; Haraguchi N; Yamamoto K; Miyake M; Nishikawa K; Omiya H; Miyazaki M; Ikeda M; Hirao M; Takami K; Sekimoto M; Nakamori S
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1454-6. PubMed ID: 26805061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing the course of pancreatic cancer--Focus on recent translational advances.
    Javle M; Golan T; Maitra A
    Cancer Treat Rev; 2016 Mar; 44():17-25. PubMed ID: 26924195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
    Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
    Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial pancreatic cancer.
    Petersen GM
    Semin Oncol; 2016 Oct; 43(5):548-553. PubMed ID: 27899186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma.
    Chapin WJ; Reiss KA
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):1019-1032. PubMed ID: 36154785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.